Internal Medicine, Cardiovascular Disease · Covington, GA
NPI
1821048042
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4140 Tate St NE
Covington, GA, 30014
Phone (770) 786-0077
Groups this clinician bills Medicare through
Medicare paid, 2024
$194K
5,148 services
Medicare patients, 2024
678
Average age 77
Drug cost, 2024
$3.3M
13,632 prescriptions
Company payments, 2025
$397
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael P Cecil was code 99214 (office e&m - established), 779 times for 481 patients. In total Michael P Cecil billed 5,148 services in 37 codes, and Medicare paid $194K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 779 | 481 | $92.11 | $72K |
| 93000 Electrocardiogram | Office | 485 | 388 | $10.50 | $5,091 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 280 | 70 | $7.02 | $1,966 |
| 93306 Echocardiography (TTE/TEE) | Office | 161 | 155 | $150.29 | $24K |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 142 | 71 | $92.64 | $13K |
| Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml | Office | 141 | 28 | $14.77 | $2,083 |
| Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | Office | 140 | 70 | $7.78 | $1,090 |
| 85610 Clinical Chemistry | Office | 139 | 16 | $4.15 | $576 |
| 99211 Office E&M - Established | Office | 134 | 23 | $17.64 | $2,364 |
| 99204 Office E&M - New | Office | 91 | 91 | $110.14 | $10K |
| 93015 Electrocardiogram | Office | 74 | 74 | $53.18 | $3,935 |
| 78452 Myocardial Perfusion Scan | Office | 70 | 70 | $350.27 | $25K |
| 93242 Electrocardiogram | Office | 39 | 37 | $9.62 | $375 |
| 93244 Electrocardiogram | Office | 36 | 34 | $17.79 | $640 |
| 93356 Echocardiography (TTE/TEE) | Office | 27 | 27 | $30.14 | $814 |
By year: 2022 $204K for 3,052 services; 2023 $242K for 7,177 services; 2024 $194K for 5,148 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 139 | 16 | $4.15 | $576 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael P Cecil prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,272 prescriptions and refills. In total Michael P Cecil wrote 13,632 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 1,272 | 2,399 | 288 | $1.4M |
| Metoprolol Succinate Generic | 1,250 | 3,265 | 380 | $16K |
| Rosuvastatin Calcium Generic | 1,095 | 3,115 | 361 | $13K |
| Atorvastatin Calcium Generic | 916 | 2,574 | 302 | $8,871 |
| Ezetimibe Generic | 802 | 2,175 | 264 | $17K |
| Amlodipine Besylate Generic | 769 | 2,067 | 249 | $4,044 |
| Spironolactone Generic | 639 | 1,605 | 205 | $3,590 |
| Telmisartan Generic | 566 | 1,592 | 179 | $16K |
| Losartan Potassium Generic | 561 | 1,517 | 203 | $4,907 |
| Entresto Sacubitril/Valsartan | 547 | 861 | 135 | $573K |
| Metoprolol Tartrate Generic | 331 | 927 | 104 | $1,938 |
| Furosemide Generic | 286 | 689 | 109 | $1,271 |
| Farxiga Dapagliflozin Propanediol | 279 | 435 | 60 | $245K |
| Carvedilol Generic | 266 | 706 | 80 | $2,239 |
| Repatha Sureclick Evolocumab | 260 | 629 | 66 | $369K |
Brand drugs: - claims; generic drugs: 10,653 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael P Cecil $397 ($397 in general payments such as food, travel and fees) from 11 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $68.52.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $68.52 |
| CVRx, Inc. CVRX | 2 | $50.33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $50.32 |
| Scpharmaceuticals Inc. SCPH | 2 | $48.45 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $41.75 |
| Abbott Laboratories ABT | 1 | $33.22 |
| Merck Sharp & Dohme LLC MRK | 1 | $33.1 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $29.08 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $19.81 |
| Amgen Inc. AMGN | 1 | $14.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.